Buprenorphine Treatment

References

• Substance Abuse and Mental Health Services Administration . 2002 . Report of the Center for Substance Abuse Work Group Federation of State Medical Boards http://www.buprenorphine.samhsa.gov/model.html. Last accessed March 21, 2003.
   Google Scholar
• Substance Abuse and Mental Health Services Administration . 2002 . About Buprenorphine Therapy http://www.buprenorphine.samhsa.gov/about.html. Last accessed March 17, 2003.
   Google Scholar
• Robinson , S E . 2002 . Buprenorphine: An analgesic with an expanding role in the treatment of opioid addiction . CNS Drug Reviews , 8 ( 4 ) : 377 – 390 .
   PubMedGoogle Scholar
• Substance Abuse and Mental Health Services Administration . 2002 . Drug Addiction Treatment Act of 2000 (DATA 2000) http://buprenorphine.samhsa.gov/titlexxxv.html. Last accessed Jan 24, 2004.
   Google Scholar
• Cowan , A . 2003 . Buprenorphine: New pharmacological aspects . Int J of Clin Prac. Supplement , 133 : 3 – 8 .
   Google Scholar
• Jasinski , D R , Pevnick , J S and Griffith , J D . 1978 . Human pharmacology and abuse potential of the analgesic buprenorphine: A potential agent for treating narcotic addiction . Arch of Gen Psych , 35 ( 4 ) : 501 – 516 .
   PubMed Web of Science ®Google Scholar
• Strain , E C , Trumble , J G and Jara , G B . 2001 . Use of Buprenorphine in the Pharmacologic Management of Opiod Dependence: A Curriculum for Physicians. Substance Abuse and Mental Health Administration http://www.buprenorphine.samhsa.gov/Buprenorphine_Curriculum.pdf. Last accessed June 27, 2005
   Google Scholar
• Raisch , D W , Fye , C L , Boardman , K D and Sather , M R . 2002 . Opioid dependence treatment including buprenorphine/ naloxone . Annals of Parmacotherapy , 36 ( 2 ) : 312 – 321 .
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration . Subtex and Suboxone Approved to Treat Opiate Dependence FDA Talk Paper, T02–38. 2002. http://www.fda.gov/bbs/topics/ANSWERS/2002/ANS01165.html,. Last accessed on February 3, 2004
   Google Scholar
• Methadone Centers . 2004 . Myths and Misconceptions http://www.methadonecenters.com/MCmyths.htm Last accessed on June 27, 2005
   Google Scholar
• Rosenblum , A , Magura , S and Joseph , H . 1991 . Ambivalence toward methadone treatment among intravenous drug users . J Psychoact Drugs , 23 ( 1 ) : 21 – 27 .
   PubMed Web of Science ®Google Scholar
• Mintzer , M Z , Correia , C J and Strain , E C . 2004 . A dose-ef-fect study of repeated administration of buprenorphine/ naloxone on performance in opioid-dependant volunteers . Drug and Alcohol Dep. , 74 ( 2 ) : 205 – 209 .
   PubMed Web of Science ®Google Scholar
• Wesson , D R . 2004 . Buprenorphine in the treatment of opiate dependence: Its pharmacology and social context of use in the US . J Psychoactive Drugs. Supplement , 2 : 119 – 128 .
   PubMed Web of Science ®Google Scholar
• Office of National Drug Control Policy . 1997 . What America's Users Spend On Illegal Drugs: 1988–1995 , Washington, DC : Executive Office of the President .
   Google Scholar
• WESTAT (submitted to The Center for Substance Abuse Treatment) . 2004 . Evaluation of the Buprenorphine Waiver: Summary of Findings From Interviews With Physicians Treating Patients With Buprenorphine , Rockville, MD : Author .
   Google Scholar
• Strain , E C , Stitzer , M L , Liebson , I A and Bigelow , G E . 1996 . Buprenorphine versus methadone in the treatment of opioid dependence: Self-reports, urinalysis, and Addiction Severity Index . J Clin Psychopharm , 16 ( 1 ) : 58 – 67 .
   PubMed Web of Science ®Google Scholar
• Strain , E C , Walsh , S L and Bigelow , G E . 2002 . Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine . Psychopharmacology , 159 ( 2 ) : 161 – 166 .
   PubMed Web of Science ®Google Scholar
• Giacomuzzi , S M , Riemer , Y , Ertl , M , Kemmler , G , Rossler , H , Hinterhuber , H and Kurz , M . 2003 . Buprenorphine versus methadone maintenance treatment in an ambulant setting: A health-related quality of life assessment . Addiction , 98 ( 5 ) : 693 – 702 .
   PubMed Web of Science ®Google Scholar
• Seifert , J , Mezner , C , Paetzold , W , Borsutszky , M , Passie , T , Rollnik , J , Wiese , B , Emrich , H M and Schneider , U . 2002 . Detoxification of opiate addicts with multiple drug abuse: A comparison of buprenorphine vs . methadone. Pharmacopsychiatry , 35 ( 5 ) : 159 – 164 .
   PubMed Web of Science ®Google Scholar
• Breen , C L , Harris , S J , Lintzeris , N , Mattick , R P , Hawken , L , Bell , J , Ritter , A J , Lenne , M and Mendoza , E . 2003 . Cessation of methadone maintenance treatment using buprenorphine: Transfer from methadone to buprenorphine and subsequent buprenorphine reductions . Drug and Alcohol Dep. , 71 : 49 – 55 .
   PubMed Web of Science ®Google Scholar
• Greenwald , M K , Schuh , K J and Stine , S M . 2003 . Transferring methadone-maintained outpatients to the buprenorphine sublingual tablet: A preliminary study . Am J Addict , 12 : 365 – 374 .
   PubMed Web of Science ®Google Scholar
• Fudala , P J , Bridge , T P , Herbert , S , Williford , W O , Chiang , C N Jones , K . 2003 . Office-based treatment of opiate addiction with a sublingual tablet formulation of buprenorphine and naloxone . N Engl J Med. , 349 ( 10 ) : 949 – 958 .
   PubMed Web of Science ®Google Scholar
• Doran , C M , Shanahan , M , Mattick , R P , Ali , R , White , J and Bell , J . 2003 . Buprenorphine versus methadone maintenance: A cost-effectiveness analysis . Drug and Alcohol Dep. , 71 ( 3 ) : 295 – 302 .
   PubMed Web of Science ®Google Scholar
• Gibson , A E , Doran , C M , Bell , J R , Ryan , A and Lintzeris , N . 2003 . A comparison of buprenorphine treatment in clinic and primary care settings: A randomized trial . Med J Australia , 179 ( 1 ) : 38 – 42 .
   PubMed Web of Science ®Google Scholar
• Burling Stacey . 2005 . Addiction drug praised, but its use restricted . The Philadelphia Inquirer , A1 February 26 : A14
   Google Scholar
• Substance Abuse and Mental Health Services Administration . 2002 . Buprenorphine Physician Locator-Fre-quently Asked Questions http://buprenorphine.samhsa.gov/bwns_locator/physician_faq.htm. Last accessed April 25, 2004
   Google Scholar
• Substance Abuse and Mental Health Services Administration . Buprenorphine Physician Locator http://buprenorphine.samhsa.gov/bwns_locator/. Last accessed August 18, 2004.
   Google Scholar
• Neighmond , P . February 27, 2004. Heroin in America: A Special Five-Part Series. National Public Radio. http://www.npr.org/features/feature.php?wfId=1718079. Accessed on 05/10/04.
   Google Scholar
• Feroni , I , Peretti-Watel , P , Paraponaris , A , Masut , A , Ronfle , E , Mabriez , J -C and Yolande , O . 2005 . French general practitioners' attitudes and prescription patterns toward buprenorphine maintained treatment: Does doctor shopping reflect buprenorphine misuse? . J Addict Dis. , 24 : 7 – 22 .
   PubMed Web of Science ®Google Scholar
• Fiellin , D A , Kleber , H , Trumble-Hejduk , J G , McLellan , A T and Kosten , T R . 2004 . Consensus statements on office-based treatment of opioid dependence using buprenorphine . J Subst Abuse Treat , 27 ( 2 ) : 153 – 159 .
   PubMed Web of Science ®Google Scholar
• Anderson , N . Letter from Norman Anderson on Buprenorphine Treatment American Psychological Association, Public Policy Office. http://www.apa.org/ppo/issues/snbaltr303.html,. Last accessedon April 27, 2004.
   Google Scholar
• McLellan , A T , Luborsky , L , Cacciola , M A , Griffith , B A , Evans , F , Barr , H L and O'Brien , C P . 1985 . New data from the Addiction Severity Index: Reliability and validity in three centers . J Nervous and Mental Disease , 173 : 412 – 423 .
   PubMed Web of Science ®Google Scholar
• McLellan , A T , Kushner , H , Metzger , D , Peters , R , Smith , I Grissom , G . 1992 . The fifth edition of the Addiction Severity Index . J Subst Abuse Treat , 9 : 199 – 213 .
   PubMed Web of Science ®Google Scholar
• Millon , T . 1997 . The millon inventories: Clinical and personality assessment , New York : Guilford Press .
   Google Scholar
• Millon , T and Davis , R D . 1997 . The MCMI-III: Present and future directions . J Personality Assessment , 68 ( 1 ) : 69 – 85 .
   PubMed Web of Science ®Google Scholar
• American Society for Addiction Medicine . Facts. Substance Abuse News and Resource Center. http://www.jointogether.org/plugin.jtml?siteID=ASAM&p=1&Tab=Facts&Object_ID=258589. Last accessed on April 27, 2004
   Google Scholar
• Donny , E C , Walsh , S L , Bigelow , G E , Eissenberg , T and Stitzer , M L . 2002 . High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans . Psychopharmacology , 161 ( 2 ) : 202 – 212 .
   PubMed Web of Science ®Google Scholar
• Mannelli , P , Gottheil , E , Buonanno , A and Risio , S D . 2003 . Use of very low-dose naltrexone during opiate detoxification . J Addict Dis. , 22 : 63 – 69 .
   PubMed Web of Science ®Google Scholar
• Montoya , I D , Schroeder , J R , Preston , K L , Covi , L , Umbricht , A , Contoreggi , C , Fudala , P J , Paul , J , Johnson , R E and Gorelick , D A . 2005 . Influence of psychotherapy attendance on buprenorphine treatment outcome . J Subst Abuse Treat , 28 ( 3 ) : 247 – 254 .
   PubMed Web of Science ®Google Scholar
• Elman , B D and Dowd , E T . 1997 . Correlates of burnout in inpatient substance abuse treatment therapists . J Addiction and Offender Counseling , 17 ( 2 ) : 56 – 65 .
   Google Scholar